Latest filing published 24 Sept 2007 for PROVECTUS BIOPHARMACEUTICALS, INC., €302k.
Insider track record
No signal scores available.
Closed purchases
Based on 3 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- -35.7%Entry US$2.55 · Close at T+365 US$1.64
- +33.9%Entry US$1.24 · Close at T+365 US$1.66
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Donald E. Adams: trading record in brief
This profile gathers the share dealings of Donald E. Adams in Provectus Biopharmaceuticals, Inc. Between 24 May 2006 and 22 September 2007, the trades on record add up to 58 filings.
In open-market terms, that means 4 purchases worth €1.2M on one side and 50 sales worth €581k on the other. Purchases outweigh sales by €571k. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. In 2007 alone, the filings show 2 purchases and 50 sales.
In size, the median ticket on the buying side is €288k. Ninety days after publication, 3 purchases show a median change of -3.2%, with the price up in 0% of them. They describe history only and say nothing certain about the share price ahead.
The latest filing, published on 24 September 2007, reports a transaction of €302k in Provectus Biopharmaceuticals, Inc. The last purchase on record was published on 24 September 2007, which is 6,985 days ago. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Donald E. Adams
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 518,657 shares@ US$0.737Common stockSEC:0001144204-07-050790:0
- 28,727 shares0Common stockSEC:0001144204-07-050790:1
- 15,000 shares@ US$1.13Common stockSEC:0001144204-07-050790:2
- 28,727 shares0Common stockSEC:0001144204-07-050780:1
- 6,000 shares@ US$1.22Common stockSEC:0001144204-07-050790:3
- 2,000 shares@ US$1.23Common stockSEC:0001144204-07-050790:4
- 6,000 shares@ US$1.20Common stockSEC:0001144204-07-050790:5
- 1,500 shares@ US$1.20Common stockSEC:0001144204-07-050790:6
- 679,048 shares@ US$1.05Common stockSEC:0001144204-07-050790:7Canonical exit: 27 Apr 2007 (T+90)
- 2,000 shares@ US$1.17Common stockSEC:0001144204-07-050790:8
- 4,000 shares@ US$1.13Common stockSEC:0001144204-07-050790:9
- 4,772 shares@ US$1.15Common stockSEC:0001144204-07-050790:10
- 8,000 shares@ US$1.12Common stockSEC:0001144204-07-050790:11
- 2,000 shares@ US$1.13Common stockSEC:0001144204-07-050790:12
- 2,000 shares@ US$1.14Common stockSEC:0001144204-07-050790:13
- 2,000 shares@ US$1.14Common stockSEC:0001144204-07-050790:14
- 4,000 shares@ US$1.15Common stockSEC:0001144204-07-050790:15
- 2,000 shares@ US$1.24Common stockSEC:0001144204-07-050790:16
- 2,000 shares@ US$1.29Common stockSEC:0001144204-07-050790:17
- 4,000 shares@ US$1.47Common stockSEC:0001144204-07-050790:18
- 630 shares@ US$1.45Common stockSEC:0001144204-07-050790:19
- 20,000 shares@ US$2.075Common stockSEC:0001144204-07-050790:20
- 25,000 shares@ US$2.40Common stockSEC:0001144204-07-050790:21
- 50,000 shares@ US$2.80Common stockSEC:0001144204-07-050790:22
- 5,000 shares@ US$2.86Common stockSEC:0001144204-07-050790:23
25 of 32 declarations